Larvol Delta - Booster-Dose-Study-to-Assess-the-Safety-and-Immunogenicity-of-ACM001-Administered-Intramuscularly-or-Intranasally

ACM-001 - ACM Biolabs

http://clinicaltrials.gov/ct2/show/NCT05385991

Jul 20, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev